Actelion Vows To Appeal Jury Verdict In Asahi Fight
Actelion Ltd. vowed Wednesday to appeal a California jury verdict ordering it to pay Asahi Kasei Pharma Corp. $547 million in damages for interfering with an Asahi drug development licensing agreement...To view the full article, register now.
Already a subscriber? Click here to view full article